PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Clinical trials for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new drug help those with a rare Heart-Lung condition walk farther?
Disease control Recruiting nowThis study tests whether adding sotatercept to usual medicines helps adults with pulmonary hypertension from unrepaired heart defects (like holes in the heart) walk farther and feel better. About 36 adults in Japan will be randomly assigned to get sotatercept injections or contin…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated May 17, 2026 01:35 UTC
-
Can your genes predict lung disease? 10,000-Person study seeks answers
Knowledge-focused Recruiting nowThis study looks at how genes influence the risk of pulmonary hypertension, a serious lung condition. Researchers aim to enroll 10,000 adults in the US, with or without the disease. Participants complete online health surveys and provide a saliva sample by mail. The goal is to fi…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC